Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Blemings

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Frontiers in Psychiatry|November 8, 2021
Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study"Meg J Spriggs, Hannah M Douglass, Rebecca J Park, et al.
Annals of the American Thoracic Society|February 2, 2018
Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical TrialRoger J Lewis, Derek C Angus, Pierre-François Laterre, et al.
JAMA|October 3, 2019
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical TrialPierre-Francois Laterre, Scott M Berry, Allan Blemings, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Frontiers in Psychiatry|November 8, 2021
Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study"Meg J Spriggs, Hannah M Douglass, Rebecca J Park, et al.
Annals of the American Thoracic Society|February 2, 2018
Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical TrialRoger J Lewis, Derek C Angus, Pierre-François Laterre, et al.
JAMA|October 3, 2019
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical TrialPierre-Francois Laterre, Scott M Berry, Allan Blemings, et al.
Pageof 2